06872.HK
TENNOR THERAP-B
HKSE · Healthcare · Biotechnology · CN
HKD 70.20
−6.40%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-99.6%
Return on equity
-67.5%
Return on assets
-65.0%
Return on invested capital
0.00x
Asset turnover
-HKD 102.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025